(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPRC5A mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1615676 6480464 1, 2-Dimethylhydrazine results in decreased expression of GPRC5A mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression ISO RGD:1603705 6480464 Ethinyl Estradiol results in decreased expression of GPRC5A mRNA CTD PMID:18936297 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of GPRC5A mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:1603705 6480464 Ethinyl Estradiol affects the expression of GPRC5A mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol affects expression ISO RGD:1603705 6480464 Estradiol affects the expression of GPRC5A mRNA CTD PMID:14699072 17beta-estradiol decreases expression ISO RGD:1603705 6480464 Estradiol results in decreased expression of GPRC5A mRNA CTD PMID:16474171 , PMID:24758408 17beta-estradiol multiple interactions ISO RGD:1603705 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GPRC5A mRNA more ... CTD PMID:20660070 more ... 17beta-estradiol increases expression ISO RGD:1603705 6480464 Estradiol results in increased expression of GPRC5A mRNA CTD PMID:20106945 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1603705 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1615676 6480464 Tetrachlorodibenzodioxin results in increased expression of GPRC5A mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615676 6480464 Tetrachlorodibenzodioxin affects the expression of GPRC5A mRNA CTD PMID:21570461 2-hydroxypropanoic acid affects expression ISO RGD:1603705 6480464 Lactic Acid affects the expression of GPRC5A mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1615676 6480464 tetrabromobisphenol A results in increased expression of GPRC5A mRNA CTD PMID:25172293 4,4'-sulfonyldiphenol increases expression ISO RGD:1615676 6480464 bis4-hydroxyphenylsulfone results in increased expression of GPRC5A mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1615676 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of GPRC5A mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1603705 6480464 Fenretinide results in increased expression of GPRC5A mRNA CTD PMID:15958647 4-hydroxyphenyl retinamide increases expression ISO RGD:1615676 6480464 Fenretinide results in increased expression of GPRC5A mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1603705 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of GPRC5A mRNA] CTD PMID:21095227 7,12-dimethyltetraphene multiple interactions ISO RGD:1615676 6480464 [9 more ... CTD PMID:32553695 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GPRC5A mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1603705 6480464 Aflatoxin B1 results in increased expression of GPRC5A mRNA CTD PMID:32234424 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of GPRC5A mRNA CTD PMID:20488242 all-trans-retinoic acid multiple interactions ISO RGD:1615676 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of GPRC5A mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of GPRC5A mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:1603705 6480464 Tretinoin results in increased expression of GPRC5A mRNA CTD PMID:16249480 more ... antirheumatic drug decreases expression ISO RGD:1603705 6480464 Antirheumatic Agents results in decreased expression of GPRC5A mRNA CTD PMID:24449571 arsenous acid decreases response to substance ISO RGD:1603705 6480464 GPRC5A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 benzo[a]pyrene decreases expression ISO RGD:1615676 6480464 Benzoapyrene results in decreased expression of GPRC5A mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1603705 6480464 Benzoapyrene results in increased expression of GPRC5A mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:1615676 6480464 [Benzoapyrene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA CTD PMID:32553695 benzo[a]pyrene increases expression ISO RGD:1615676 6480464 Benzoapyrene metabolite results in increased expression of GPRC5A mRNA, Benzoapyrene results in increased expression of GPRC5A mRNA CTD PMID:32417428 , PMID:32553695 benzo[a]pyrene decreases methylation ISO RGD:1603705 6480464 Benzoapyrene results in decreased methylation of GPRC5A 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1603705 6480464 7 more ... CTD PMID:19150397 bicalutamide decreases expression ISO RGD:1603705 6480464 bicalutamide results in decreased expression of GPRC5A mRNA CTD PMID:15638997 bis(2-chloroethyl) sulfide increases expression ISO RGD:1603705 6480464 Mustard Gas results in increased expression of GPRC5A mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1603705 6480464 Diethylhexyl Phthalate results in increased expression of GPRC5A mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1603705 6480464 bisphenol A results in decreased expression of GPRC5A mRNA CTD PMID:16474171 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GPRC5A mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:1603705 6480464 bisphenol A affects the expression of GPRC5A mRNA CTD PMID:20170705 bisphenol F multiple interactions ISO RGD:1615676 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of GPRC5A mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1615676 6480464 bisphenol F results in increased expression of GPRC5A mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1603705 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPRC5A mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1603705 6480464 butyraldehyde results in increased expression of GPRC5A mRNA CTD PMID:26079696 cadmium sulfate increases expression ISO RGD:1603705 6480464 cadmium sulfate results in increased expression of GPRC5A mRNA CTD PMID:12064557 , PMID:14676411 carbon nanotube affects expression ISO RGD:1615676 6480464 Nanotubes, Carbon affects the expression of GPRC5A protein CTD PMID:21135415 carbon nanotube increases expression ISO RGD:1615676 6480464 Nanotubes more ... CTD PMID:25620056 cobalt dichloride increases expression ISO RGD:1603705 6480464 cobaltous chloride results in increased expression of GPRC5A mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:1603705 6480464 Copper Sulfate results in increased expression of GPRC5A mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1603705 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:1603705 6480464 Coumestrol results in decreased expression of GPRC5A mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1615676 6480464 Asbestos, Crocidolite results in decreased expression of GPRC5A mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1603705 6480464 Cyclosporine results in decreased expression of GPRC5A mRNA CTD PMID:22147139 cyclosporin A increases expression ISO RGD:1603705 6480464 Cyclosporine results in increased expression of GPRC5A mRNA CTD PMID:20106945 more ... cylindrospermopsin increases expression ISO RGD:1603705 6480464 cylindrospermopsin results in increased expression of GPRC5A mRNA CTD PMID:24921660 diarsenic trioxide decreases response to substance ISO RGD:1603705 6480464 GPRC5A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibutyl phthalate increases expression ISO RGD:1615676 6480464 Dibutyl Phthalate results in increased expression of GPRC5A mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1603705 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GPRC5A mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1603705 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of GPRC5A mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1603705 6480464 entinostat results in increased expression of GPRC5A mRNA CTD PMID:27188386 ferroheme b increases expression ISO RGD:1615676 6480464 Heme metabolite results in increased expression of GPRC5A mRNA CTD PMID:19191707 furan increases expression EXP 6480464 furan results in increased expression of GPRC5A mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:1603705 6480464 Genistein results in decreased expression of GPRC5A mRNA CTD PMID:16474171 genistein affects expression ISO RGD:1603705 6480464 Genistein affects the expression of GPRC5A mRNA CTD PMID:26865667 glycidol increases expression EXP 6480464 glycidol results in increased expression of GPRC5A mRNA CTD PMID:24915197 Heliotrine increases expression ISO RGD:1603705 6480464 heliotrine results in increased expression of GPRC5A mRNA CTD PMID:26100227 heme b increases expression ISO RGD:1615676 6480464 Heme metabolite results in increased expression of GPRC5A mRNA CTD PMID:19191707 hydrogen peroxide affects expression ISO RGD:1603705 6480464 Hydrogen Peroxide affects the expression of GPRC5A mRNA CTD PMID:20044591 hydroquinone decreases expression ISO RGD:1603705 6480464 hydroquinone results in decreased expression of GPRC5A mRNA CTD PMID:31256213 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of GPRC5A mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of GPRC5A mRNA CTD PMID:16629162 menadione affects expression ISO RGD:1603705 6480464 Vitamin K 3 affects the expression of GPRC5A mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RGD:1603705 6480464 mercuric bromide results in increased expression of GPRC5A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1603705 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GPRC5A mRNA CTD PMID:27188386 methotrexate increases expression ISO RGD:1603705 6480464 Methotrexate results in increased expression of GPRC5A mRNA CTD PMID:17379860 O-methyleugenol increases expression ISO RGD:1603705 6480464 methyleugenol results in increased expression of GPRC5A mRNA CTD PMID:32234424 paracetamol increases expression ISO RGD:1603705 6480464 Acetaminophen results in increased expression of GPRC5A mRNA CTD PMID:21420995 phenobarbital affects expression ISO RGD:1615676 6480464 Phenobarbital affects the expression of GPRC5A mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1603705 6480464 Phenylmercuric Acetate results in increased expression of GPRC5A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1603705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GPRC5A mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1603705 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GPRC5A mRNA CTD PMID:19710929 progesterone multiple interactions ISO RGD:1603705 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GPRC5A mRNA CTD PMID:20660070 propanal increases expression ISO RGD:1603705 6480464 propionaldehyde results in increased expression of GPRC5A mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1603705 6480464 Quercetin results in increased expression of GPRC5A mRNA CTD PMID:21632981 rac-lactic acid affects expression ISO RGD:1603705 6480464 Lactic Acid affects the expression of GPRC5A mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1603705 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of GPRC5A mRNA CTD PMID:19167446 Salinomycin decreases expression ISO RGD:1603705 6480464 salinomycin results in decreased expression of GPRC5A mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:1603705 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 senecionine increases expression ISO RGD:1603705 6480464 senecionine results in increased expression of GPRC5A mRNA CTD PMID:26100227 Senkirkine increases expression ISO RGD:1603705 6480464 senkirkine results in increased expression of GPRC5A mRNA CTD PMID:26100227 silicon dioxide increases expression ISO RGD:1603705 6480464 Silicon Dioxide analog results in increased expression of GPRC5A mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1615676 6480464 Silicon Dioxide results in increased expression of GPRC5A mRNA CTD PMID:29203145 silver atom increases expression ISO RGD:1603705 6480464 Silver results in increased expression of GPRC5A mRNA CTD PMID:28959546 silver atom increases expression ISO RGD:1615676 6480464 Silver results in increased expression of GPRC5A mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1603705 6480464 Silver results in increased expression of GPRC5A mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:1615676 6480464 Silver results in increased expression of GPRC5A mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1615676 6480464 sodium arsenate results in decreased expression of GPRC5A mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1603705 6480464 sodium arsenite results in decreased expression of GPRC5A mRNA CTD PMID:28595984 Soman increases expression EXP 6480464 Soman results in increased expression of GPRC5A mRNA CTD PMID:19281266 sulforaphane decreases expression ISO RGD:1603705 6480464 sulforafan results in decreased expression of GPRC5A mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1603705 6480464 Sunitinib results in decreased expression of GPRC5A mRNA CTD PMID:31533062 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPRC5A mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GPRC5A mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1615676 6480464 titanium dioxide results in decreased expression of GPRC5A mRNA CTD PMID:23409001 Tributyltin oxide increases phosphorylation ISO RGD:1615676 6480464 bistri-n-butyltinoxide results in increased phosphorylation of GPRC5A protein CTD PMID:22174045 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1603705 6480464 tris2-butoxyethyl phosphate affects the expression of GPRC5A mRNA CTD PMID:29024780 valproic acid increases methylation ISO RGD:1603705 6480464 Valproic Acid results in increased methylation of GPRC5A gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1603705 6480464 Valproic Acid results in increased expression of GPRC5A mRNA CTD PMID:23179753 , PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GPRC5A mRNA CTD PMID:19015723 zoledronic acid decreases expression ISO RGD:1603705 6480464 zoledronic acid results in decreased expression of GPRC5A mRNA CTD PMID:24714768
